Global Evidence Summit in Cape Town
Ejemai Eboreime: The Global Evidence Summit was an inter-sectoral and multi-disciplinary conference to promote and exchange ideas about how synthesize and communicate evidence to inform policy and practice worldwide. The conference had five plenary sessions and several satellite events to discuss a range of issues ranging from systematic reviews, rapid evidence synthesis, dissemination and implementation, among others.
I obtained a bursary from the Campbell collaboration to participate in the conference. I made a poster presentation titled “Implementing a model for improving integrated primary healthcare planning and performance: an effectiveness evaluation of DIVA in Kaduna, Nigeria” on Saturday 16th September 2017. My presentation was well attended and generated lots of questions and debates relating to how PHC strengthening interventions can be effectively implemented in LMICs.
Besides the academic component of the conference, the event provided an opportunity for strategic networking as well as touring the beautiful city.
Kafayat Oboirien: The Global Health Summit brought together, researchers in different areas of work as well as policy makers and health care practitioners. The broad message from the summit is on how to increase the production of evidence as well as its syntheses and quality, in order to inform best practices and responsive policies. There is also an increasing expectation that the use of evidence based decision making is broader than health and socio-economic policy. There is a need to move from existing decision making practices that are not evidence based or lacking the appropriate networks and collaboration.
I also presented part of my PhD work titled: Strengthening Clinical Governance in Low and Middle Income Countries (LMICs): A systematic (scoping) Review’. This work was co-authored by Jane Goudge, Bronwyn Harris, Faith Mambulu, Teurai Rwafa, John Eyles and Frances Griffiths. Preliminary findings from the poster presentation suggests limited reporting of evidence on clinical governance in LMICs. Further analysis is also required to map clinical governance strategies, successes and challenges in LMICs.